Aleksandra Balak
Aleksandra Balak has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Fałczyńska
Poznan University of Medical Sciences
2 shared publications - Katarzyna Rotte2 shared publications
- Maksymilian Grabarczyk
Student’s Research Group “Biology of the Neuron”, Department of Psychiatric Genetics, Poznan University of Medical Sciences, 60-806 Poznan, Poland
2 shared publications - Roksana Grzeszczak
Oddział Internistyczno-Kardiologiczny z Pododdziałem Intensywnego Nadzoru Internistyczno-Kardiologicznego, Szpital Wojewódzki w Poznaniu, Wielkopolskie Centrum Specjalistyczne, Polska
2 shared publications - Agnieszka Głownia1 shared publication
- Emilia Bachoń
Clinical Hospital in Poznan, Przybyszewskiego 49, 60-355 Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Managing Refractoriness: Modern Strategy for Refractory Celiac Disease
Celiac disease (CD), also known as gluten-sensitive enteropathy, is the most common autoimmune disorder in today’s society. CD is associated with both human leukocyte antigen (HLA) and non-HLA genes. It often coexists with other autoimmune diseases, such as juvenile diabetes and thyroid disease. Diagnosis often relies on biopsy results, but serological tests are also very useful when screening patients suspected of having CD. Although our knowledge of celiac disease seems thorough, the pathogenesis of refractory celiac disease (RCD) is still under research. Treating RCD can be challenging, and it is crucial to provide care in experienced tertiary centers. Treatment may involve dietary and pharmacological approaches, depending on the type of RCD. This reduces the risk of disease progression and alleviates the symptoms. Investigations into other innovative treatment methods are ongoing.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessManaging Refractoriness: Modern Strategy for Refractory Celiac Disease
Celiac disease (CD), also known as gluten-sensitive enteropathy, is the most common autoimmune disorder in today’s society. CD is associated with both human leukocyte antigen (HLA) and non-HLA genes. It often coexists with other autoimmune diseases, such as juvenile diabetes and thyroid disease. Diagnosis often relies on biopsy results, but serological tests are also very useful when screening patients suspected of having CD. Although our knowledge of celiac disease seems thorough, the pathogenesis of refractory celiac disease (RCD) is still under research. Treating RCD can be challenging, and it is crucial to provide care in experienced tertiary centers. Treatment may involve dietary and pharmacological approaches, depending on the type of RCD. This reduces the risk of disease progression and alleviates the symptoms. Investigations into other innovative treatment methods are ongoing.
- 1 January 2020
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Medycyna Nowożytna
- Vol. 26 (2) , 9-20
Plica neuropathica – unraveling the mystery of Plica polonica
Background: Plica as a disease entity appeared fi rst in the 13th century. Its aetiology is still unknown and not fully understood. Being, in fact, an irreversible condition of tangling and felting the hair, its origin was interpreted in various ways, from religious ones, through lack of hygiene to mental illness. Although p. polonica originates from Eastern and Central Europe, and p. neuropathica, typical of Indian people, was fi rst described in England, many characteristics connect these two conditions. Aim and Objectives: The study aimed to review the plica species over the centuries and to compare p. neuropathica and p. polonica. Materials and Methods: PubMed and Google Scholar databases were searched for medical articles, books and case studies on plica published up 1884 to 2020. We conducted a systematic and critical review of the literature to compare p. polonica and p. neuropathica. Results: Plica polonica and Plica neuropathica are the same disease entity. Conclusion: The variety of names and interpretations of the disease has made plica a condition still to be fully explained.
- 1 January 2020
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Medycyna Nowożytna
- Vol. 26 (2) , 9-20
Plica neuropathica – unraveling the mystery of Plica polonica
Background: Plica as a disease entity appeared fi rst in the 13th century. Its aetiology is still unknown and not fully understood. Being, in fact, an irreversible condition of tangling and felting the hair, its origin was interpreted in various ways, from religious ones, through lack of hygiene to mental illness. Although p. polonica originates from Eastern and Central Europe, and p. neuropathica, typical of Indian people, was fi rst described in England, many characteristics connect these two conditions. Aim and Objectives: The study aimed to review the plica species over the centuries and to compare p. neuropathica and p. polonica. Materials and Methods: PubMed and Google Scholar databases were searched for medical articles, books and case studies on plica published up 1884 to 2020. We conducted a systematic and critical review of the literature to compare p. polonica and p. neuropathica. Results: Plica polonica and Plica neuropathica are the same disease entity. Conclusion: The variety of names and interpretations of the disease has made plica a condition still to be fully explained.